PR Newswire DAEJEON, South Korea, Oct. 14, 2024 DAEJEON, South Korea, Oct. 14, 2024 /PRNewswire/ -- PharmAbcine, Inc. (KOSDAQ: 208340), a clinical-stage public company developing next-generation therapeutics to address unmet medical needs, ...
PR Newswire SAN DIEGO, Oct. 9, 2024 Reductions in Very Long-Chain Fatty Acids and Plasma Lipid Levels Observed After 28 Days of Once Daily Dosing VK0214 Shown to be Safe and Well-Tolerated in 28-Day Study SAN DIEGO, Oct. 9, 2024 ...
PR Newswire WASHINGTON, Oct. 8, 2024 Opening Doors to Clinical Trials national initiative creates a movement to increase diversity in clinical trials. WASHINGTON, Oct. 8, 2024 /PRNewswire-PRWeb/ -- Despite alarmingly low levels of ...
PR Newswire PHILADELPHIA, Oct. 8, 2024 Clinical-stage CAR-T company enrolling patients for Phase 1 trial to evaluate SynKIR™-310, a new treatment for relapsed/refractory B-cell Non-Hodgkin Lymphomas PHILADELPHIA, Oct. 8, 2024 ...
PR Newswire NEW YORK, Oct. 8, 2024 Dosing of patients in the second clinical research program for radiprodil follows recent announcement of positive topline data from the Honeycomb trial in GRIN-related neurodevelopmental disorder; ...
PR Newswire WOBURN, Mass., Oct. 8, 2024 First-in-human study in patients with solid tumors initially evaluating the safety, tolerability pharmacokinetics and target engagement of RGT-61159 WOBURN, Mass., Oct. 8, 2024 /PRNewswire/ -- ...
PR Newswire PLANTATION, Florida and HOUSTON, Texas, Oct. 7, 2024 PLANTATION, Florida and HOUSTON, Texas, Oct. 7, 2024 /PRNewswire/ -- GBI Biomanufacturing, a leading Contract Development and Manufacturing Organization (CDMO), and Allterum ...
PR Newswire TAIPEI, Oct. 7, 2024 TAIPEI, Oct. 7, 2024 /PRNewswire/ -- TCI Co., Ltd. ("TCI"), a global CDMO leader in health and skincare solutions, is pleased to announce the successful results of its recent clinical trial of the GLP-1 ...
PR Newswire BOSTON, Oct. 3, 2024 DATAcc is creating an open-source industry guide to address market challenges by bringing clarity on how and why to include digital endpoints in clinical trials BOSTON, Oct. 3, 2024 /PRNewswire/ -- Today, ...
PR Newswire TORONTO, Oct. 1, 2024 In this free webinar, learn how real-world data (RWD) can streamline patient recruitment, enhance diversity and support compliance with the US Food and Drug Administration (FDA) guidelines for running ...
A new clinical trial explores whether targeted steam therapy can offer a less invasive, effective treatment for prostate cancer.
Vanderbilt’s Phase I trial of VU319 demonstrates promising results for Alzheimer’s and schizophrenia
Late-breaking research finds no survival benefit from autologous stem cell transplant in mantle cell lymphoma patients with undetectable MRD.
Hypovolemic phlebotomy, removing 10% of blood before liver surgery, can cut transfusion needs by 50%, offering a safe, cost-effective way to reduce surgery risks.
Felzartamab, an investigational antibody, reduces triggers linked to IgA nephropathy, an autoimmune kidney disease, suggesting lasting clinical benefits.
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers